Cargando…
Development and structure–activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors
11β-Hydroxysteroid dehydrogenase 1 (11β-HSD1) represents a promising drug target for metabolic syndrome, including obesity and type 2 diabetes. Our initial screen of a collection of natural products from Danshen led to the identification of tanshinones as the potent and selective 11β-HSD1 inhibitors...
Autores principales: | Deng, Xu, Huang, Su-Ling, Ren, Jian, Pan, Zheng-Hong, Shen, Yu, Zhou, Hao-Feng, Zuo, Zhi-Li, Leng, Ying, Zhao, Qin-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492458/ https://www.ncbi.nlm.nih.gov/pubmed/36131216 http://dx.doi.org/10.1007/s13659-022-00358-9 |
Ejemplares similares
-
11β-Hydroxysteroid Dehydrogenase 2 in Preeclampsia
por: Kosicka, Katarzyna, et al.
Publicado: (2016) -
11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
por: Bailey, Matthew A.
Publicado: (2017) -
A novel selective 11β-hydroxysteroid dehydrogenase type 1
inhibitor prevents human adipogenesis
por: Bujalska, I J, et al.
Publicado: (2008) -
The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity
por: Nakata, Takaya, et al.
Publicado: (2016) -
Diethylstilbestrol inhibits human and rat 11β-hydroxysteroid dehydrogenase 2
por: Wang, Yiyan, et al.
Publicado: (2019)